Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02123121 · ClinicalTrials.gov registry record · Phase 2
Resveratrol to Enhance Vitality and Vigor in Elders
A Phase 2 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT02123121: Completed Phase 2 study, sponsored by University of Florida.
NCT02123121 is a Phase 2 study that has completed, run by University of Florida. The registered enrollment target is 60 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02123121, a Phase 2 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
Resveratrol, a compound found in red wine and dark-skinned grapes, will improve the function of mitochondria (energy producing components) within the leg muscles of moderate functioning older adults. The investigators will look at the role Resveratrol plays in improving physical function by studying the connection of changes in mitochondrial function and changes in physical function.
Primary Outcome
Change in mitochondrial respiration (State 3) in muscle samples of moderate-to-low functioning older adults from baseline to post-test (90 days).
Interventions
- DRUG Resveratrol 1000 mg/day
- DRUG Resveratrol 1500 mg/day
- OTHER Vegetable cellulose
- OTHER All groups
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2015-09 |
| Est. Completion | 2019-05-02 |
| Phase | Phase 2 |
What the finished NCT02123121 record still lists
NCT02123121 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (55% lower).
The record links to 0 conditions, and to 4 interventions - of which Resveratrol 1000 mg/day is the first listed.
NCT02123121 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02123121 about?
NCT02123121 is a clinical study titled "Resveratrol to Enhance Vitality and Vigor in Elders". Resveratrol, a compound found in red wine and dark-skinned grapes, will improve the function of mitochondria (energy producing components) within the leg muscles of moderate functioning older adults. The investigators will look at the role Resveratrol plays in improving physical function by studyin...
What is the current status of trial NCT02123121?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2015-09. Estimated completion is 2019-05-02.
What interventions are being tested in trial NCT02123121?
The interventions under investigation include: Resveratrol 1000 mg/day (DRUG), Resveratrol 1500 mg/day (DRUG), Vegetable cellulose (OTHER), All groups (OTHER).
Who is sponsoring clinical trial NCT02123121?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02123121's enrollment target sits among peer trials
60 1027th of 2000 higher than 868 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia